Hua Medicine Announces New Hong Kong Address

Hua Medicine (HK:2552) has released an update.

Hua Medicine, a company incorporated in the Cayman Islands, has announced that effective July 19, 2024, their principal place of business in Hong Kong will move from its current location to the Hang Seng Wanchai Building. The notice was issued by the CEO, Dr. Li Chen, confirming the company’s continued presence in the region. Investors and clients should note the change in address for any direct inquiries or business relations.

For further insights into HK:2552 stock, check out TipRanks’ Stock Analysis page.